IPSEY Stock Price Chart
IPSEY Earnings
Ipsen S.A.
$48.86
-3.63%
$-1.84
At close: May 08, 16:00:00 GMT-4
$48.86
0%
$0
Post-market: May 08, 20:00:00 GMT-4
Back
Ipsen S.A. (IPSEY) Earnings
Key Stats
Prev.Close
$50.7
Open
$48.86
Day's Range
$48.86 - $50.88
52 week range
$28.03 - $51.1
Volume
2
Avg.Volume
806
Dividend yield
--
EPS (TTM)
1.56
Market Cap
$16.1B
What is Ipsen S.A.?
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. The company is headquartered in Boulogne-Billancourt, Ile-De-France and currently employs 5,358 full-time employees. The company went IPO on 2005-12-06. The firm operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, Cabometyx and Onivyde. Its neuroscience portfolio includes Dysport, and in rare diseases key products are NutropinAq and Increlex. Its primary care portfolio includes Smecta, Forlax, Fortrans, Eziclen, and Tanakan. In oncology Ipsen focuses on a number of disease areas, which include neuroendocrine tumors, renal cell carcinoma, hepatocellular carcinoma and pancreatic cancer. In addition, the Company has specialism in neurotoxin research and operates three research and development centers located in France, the United Kingdom and the United States.
